FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2544-2546 December 9, 2004 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Rose, P. G. PubMed Citation

Celomic epithelial carcinoma of the ovary, in contrast to most other gynecologic cancers, often causes no symptoms in its early stages and is usually diagnosed only after it has spread to other parts of the peritoneal cavity or to more distant sites. As a result, curative surgical resection is not an option for most patients. Moreover, ovarian carcinoma, unlike most other solid tumors, typically spreads by seeding throughout the peritoneal cavity. For these reasons, the disease is most commonly diagnosed at stage III, in which the process is grossly confined to the peritoneal cavity. Such cases are not amenable to . . . [Full Text of this Article]

Source Information

From the Division of Oncology, Department of Medicine, University of Mississippi School of Medicine, Jackson.

This article has been cited by other articles:

• Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., Burger, R. A., the Gynecologic Oncology Group, (2006). Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer. NEJM 354: 34-43 [Abstract] [Full Text]